Use of systemic therapies for psoriasis in the COVID-19 era

Use of systemic therapies for psoriasis in the COVID-19 era

Background In late 2019 a viral pneumonia began to spread across the world. The viral disease, COVID-19, is now officially a pandemic, causing concern for the potential risk of systemic therapies for patients with psoriasis. Objective The purpose of this review is to analyze what is currently known...

Full description

Bibliographic Details
Main Authors: Donovan G. Kearns, Shelley Uppal, Vipawee S. Chat, Jashin J. Wu
Format: Article
Language:English
Published: Taylor & Francis Group 2022-02-01
Series:Journal of Dermatological Treatment
Subjects:
covid-19
biologic
systemic treatment
immunosuppressant
psoriasis
Online Access:http://dx.doi.org/10.1080/09546634.2020.1775774

Internet

http://dx.doi.org/10.1080/09546634.2020.1775774

Similar Items